NCT06394934 Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients
| NCT ID | NCT06394934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Korea University Anam Hospital |
| Condition | Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,188 participants |
| Start Date | 2024-01-09 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,188 participants in total. It began in 2024-01-09 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 19 years or older. 2. Diagnosed with hypertension. 3. Regular use of antihypertensive medication for at least two years. 4. Access to a home blood pressure monitor. 5. Comprehensive medical records available for the past year. Exclusion Criteria: 1\. Participants who are unable to consent or who might not reliably use the home monitoring app.
Contact & Investigator
Hyung Joon Joo, MD PhD
PRINCIPAL INVESTIGATOR
Korea University Anam Hospital
Frequently Asked Questions
Who can join the NCT06394934 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06394934 currently recruiting?
Yes, NCT06394934 is actively recruiting participants. Contact the research team at jh2bac@gmail.com for enrollment information.
Where is the NCT06394934 trial being conducted?
This trial is being conducted at Seoul, South Korea, Seoul, South Korea.
Who is sponsoring the NCT06394934 clinical trial?
NCT06394934 is sponsored by Korea University Anam Hospital. The principal investigator is Hyung Joon Joo, MD PhD at Korea University Anam Hospital. The trial plans to enroll 4,188 participants.